Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives.
about
A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantationPostoperative Cognitive Dysfunction: Minding the Gaps in Our Knowledge of a Common Postoperative Complication in the ElderlyCancer chemotherapy impairs contextual but not cue-specific fear memoryFluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy.Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations.Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusionMemory and cancer: a review of the literatureCognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer.Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors.Neurotoxicity of cancer chemotherapy.IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice.Neuropsychological care and rehabilitation of cancer patients with chemobrain: strategies for evaluation and intervention development.A Brief Patient Self-Report Screening Measure of Cancer Treatment-Related Memory Problems: Latent Structure and Reliability AnalysisManagement of Cancer-related Cognitive Dysfunction-Conceptualization Challenges and Implications for Clinical Research and Practice.Leukoencephalopathy and disseminated necrotizing leukoencephalopathy following intrathecal methotrexate chemotherapy and radiation therapy for central nerve system lymphoma or leukemia.Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in micePrevalence of self-reported memory problems in adult cancer survivors: a national cross-sectional studySelf-reported memory problems in adult-onset cancer survivors: effects of cardiovascular disease and insomniaCandidate mechanisms for chemotherapy-induced cognitive changes.Population-based exploration of academic achievement outcomes in pediatric acute lymphoblastic leukemia survivors.Brain metabolomic profiles of lung cancer patients prior to treatment characterized by proton magnetic resonance spectroscopyAlterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study.Reduced prefrontal activation during working and long-term memory tasks and impaired patient-reported cognition among cancer survivors postchemotherapy compared with healthy controls.Learning and memory following conformal radiation therapy for pediatric craniopharyngioma and low-grade gliomaHow chemotherapy damages the central nervous systemFrontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study.Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study.Neuroimaging, cancer, and cognition: state of the knowledge.Consistency and construct validity of the Activity Card Sort (modified) in measuring activity resumption after stem cell transplantation.Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors.Decreased postural control in adult survivors of childhood cancer treated with chemotherapy.Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?Proton MR spectroscopy correlates of frontal lobe function in healthy childrenNeuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research.Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats.Brain volume and cognitive function in adult survivors of childhood acute lymphoblastic leukemia.Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: protocol for a scoping review.Feasibility of a combined aerobic and cognitive training intervention on cognitive function in cancer survivors: a pilot investigation.Do Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials?
P2860
Q27013566-AEA8A0FB-D034-49A7-B71D-8A7DE9C3805AQ28086981-1FA4FD69-FA2F-4410-A35D-60193DEECC96Q30438754-48BDAD1B-A3AF-4320-996A-51AFE6F7CE17Q30499383-BD1F19AF-79AF-4D98-87D8-5D944BDA4265Q30664513-86D33006-3D29-4F2B-BF22-830BE5FA036CQ33590378-BDF7D5EC-5AD1-45D6-8531-180107FC1A63Q33663544-508A240A-D061-4D0B-A2D6-62C8C76A6DEFQ33729085-FD1D9D22-B90B-4ABB-8DC1-C8102BACCD05Q33816589-83F1BC83-5681-4EC6-8FC2-A723FEA382F7Q34031141-1FB3A8FF-F1A5-40A4-B6CA-D1C3C792F278Q34094753-795308C7-0D5F-43C6-832E-BCCA3DBED602Q34508233-7F8ADEE2-0C07-44D6-9BC6-D3664E7869AAQ34633028-2AAD3E4C-414C-443F-A6C1-F9E2C27280D8Q35037127-F5DD3714-826E-42EA-8E24-C244540C3FD7Q35427635-E088B2BB-122A-4AA7-A0E5-E81ABECD779CQ35627088-571EECFA-21BF-4E68-8F3A-FF1C5D8BFAE6Q35644334-A6DC2C1C-FEF7-4C55-A58C-1A2D1881177AQ35695833-8461A180-321D-45C4-B477-88084030F040Q35738596-823371A1-9FCF-4B0D-A8F8-6911A3C1F878Q35898051-EE392583-B0BF-4495-936F-ED54BECD0D55Q35907493-C3B0A235-F83A-417C-934C-FEC672B1A1F8Q35929573-CE94C545-1941-4F6E-8C82-9F1561E24A9EQ36097701-853F51E9-58B6-40AD-B975-192FB75C27FFQ36450200-15F7D6DF-5B65-45CC-B7BE-EAEF2FBB385CQ36501197-2B9C2DBF-18EC-471E-9DE9-D283B96E1E64Q36678547-3DE11BDE-CF75-488F-A4EC-0C1DECDB08B0Q36775693-84DF8419-08C0-4C40-AEF2-F25DB3C4A0E0Q36867082-BEA9BD03-8B43-421C-A312-759C874F5C54Q37292321-C8997373-4EEE-412B-BEA4-A40EDBADCF6BQ37362483-EA3822B2-78C6-4AD2-8C69-A500A917E2B7Q37382652-A98F77B9-B73A-40F8-AAC1-E2D420BD23CDQ37405604-F080AAAA-E982-4553-967C-4ECCC6DC42A5Q37431101-4E4B3CB8-FD00-47F5-926E-D9568F7E1297Q37436569-B0371E1F-45A6-4E5E-A979-CC2B3616FD2EQ37540122-D187D76C-8542-455D-8DF7-AF791F355118Q37641278-A643B1DF-5066-42D4-8E15-B69ADE2642D4Q40033058-35359A5B-5F55-49D4-9740-464EB919CA9CQ47709070-97B4CA0C-2F9B-4724-A900-F6668E073960Q50283138-CE017B36-81C7-404A-A927-959ADDDD7697Q56520646-A301B1B6-1714-440E-AB44-8125DCF04108
P2860
Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Mechanisms of chemotherapy-ind ...... and neuroimaging perspectives.
@ast
Mechanisms of chemotherapy-ind ...... and neuroimaging perspectives.
@en
type
label
Mechanisms of chemotherapy-ind ...... and neuroimaging perspectives.
@ast
Mechanisms of chemotherapy-ind ...... and neuroimaging perspectives.
@en
prefLabel
Mechanisms of chemotherapy-ind ...... and neuroimaging perspectives.
@ast
Mechanisms of chemotherapy-ind ...... and neuroimaging perspectives.
@en
P921
P1476
Mechanisms of chemotherapy-ind ...... and neuroimaging perspectives.
@en
P2093
Andrew J Saykin
Tim A Ahles
P304
P577
2003-10-01T00:00:00Z